Mallick, R.
Solomon, G.
Bassett, P.
Zhang, X.
Patel, P.
Lepeshkina, O.
Funding for this research was provided by:
CSL Behring
Article History
Received: 4 November 2022
Accepted: 7 February 2024
First Online: 20 February 2024
Declarations
:
: Following review of the final questionnaire and protocol by the coordinator of the Ethics Unit at the Centre Hospitalier de l'Université Sainte-Justine, Montreal, Canada, ethics approval was deemed not necessary for this non-interventional survey. Furthermore, the survey was carried out in accordance with relevant Canadian guidelines and regulations [CitationRef removed, CitationRef removed]. In addition, all respondents provided electronic informed consent to participate prior to initiation of the survey [CitationRef removed].
: Not applicable.
: RM and XZ are full-time employees of and own stocks in CSL Behring. GS works for the APIQ, a patient advocacy group that facilitated the planning and execution of the survey, which was sponsored by CSL Behring. PB is an employee of Meridian HealthComms Ltd. PP is a former employee of CSL Behring. OL has no conflicts to declare.